This is a Validated Antibody Database (VAD) review about equine EGFR, based on 4 published articles (read how Labome selects the articles), using EGFR antibody in all methods. It is aimed to help Labome visitors find the most suited EGFR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
EGFR synonym: epidermal growth factor receptor
Invitrogen
mouse monoclonal (EGFR.1) |
| In order to use nonlinear and multiplexed illumination to get high-resolution and deep three-dimensional tracking of single particles, Invitrogen EGFR antibody (Thermo Scientific, MS-311-B) was used in immunocytochemistry on human samples (fig s9). Nat Commun (2015) ncbi |
mouse monoclonal (EGFR.1) |
| In order to describe histological features of a tumor from a patient with pleuropulmonary blastoma, Invitrogen EGFR antibody (Lab Vision, EGFR.113) was used in immunohistochemistry on human samples . Fetal Pediatr Pathol (2014) ncbi |
mouse monoclonal (EGFR.1) |
| In order to use gold nanoparticles and ultrashort pulses to kill cancer cells, Invitrogen EGFR antibody (Lab Vision, EGFR.1) was used in immunocytochemistry on human samples (fig s1). Sci Rep (2013) ncbi |
mouse monoclonal (EGFR.1) |
| In order to investigate the sub-classification invasive breast carcinoma patients and its prognostic significance, Invitrogen EGFR antibody (Lab Vision/Neomarkers, EGFR.113) was used in immunohistochemistry on human samples at 1:25 (tbl 3). Cancer (2007) ncbi |
Articles Reviewed
- Goldstein N, Decker D, Severson D, Schell S, Vicini F, Margolis J, et al. Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2007;110:1687-96 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments